Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales Posted byZacks Equity Research February 3, 2022 Leave a comment on Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales Eli Lilly (LLY) misses earnings estimates in the fourth quarter while revenues beat the same. Stock down in pre-market trading.